A. Scott Gangloff

Affiliations

  • Chief Technology Officer at Akero Therapeutics Inc. (AKRO), 2025-06-21
  • Svp, Development & Mfrg at Oncobiologics Inc. (ONS), 2016-12-22
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AKRO $54.84 848 $46,504.32 23,452 2025-06-18 Filing
ONS $3.75 37,369 $140,133.75 78,573 2016-11-11 Filing